adrenal incidentalomas have become an important clinical entity for which pheochromocytoma must be considered, regardless of signs and symptoms. Third, knowledge of the relationship between ...
Bilateral optic disc swelling is an important clinical sign that can reflect a ... or as a first consultation by a patient with visual symptoms. The diagnosis of idiopathic intracranial ...
The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...
The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for belzutifan for the treatment of adult and pediatric patients aged 12 years and ...
The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.
Patients diagnosed with pheochromocytoma or paraganglioma ... describes the development and clinical impact of this drug, high-specific-activity iodine-131 metaiodobenzylguanidine (HSA-MIBG ...
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback